Adjuvant Chemotherapy Compliance Is Not Superior After Thoracoscopic Lobectomy

Complete national data do not support the widespread assumption that adjuvant chemotherapy compliance is superior after thoracoscopic lobectomy for NSCLC. Instead, significant predictors of chemotherapy compliance are patient's age, comorbidity, and pathologic N status.